Artwork

Content provided by Matt and Chris Johnson and Chris Johnson. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Matt and Chris Johnson and Chris Johnson or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ppacc.player.fm/legal.
Player FM - Podcast App
Go offline with the Player FM app!

248. What If They're All Wrong About GLP-1 Medications?

21:30
 
Share
 

Manage episode 465065632 series 3047232
Content provided by Matt and Chris Johnson and Chris Johnson. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Matt and Chris Johnson and Chris Johnson or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ppacc.player.fm/legal.

In this thought-provoking episode, Matt challenges the current narrative surrounding GLP-1 medications (like Ozempic and Wegovy) and obesity treatment.

He poses a crucial question: Are we focusing too much on survival instead of helping people truly thrive?

Key Points:

• The difference between surviving and thriving in healthcare

• Why treating obesity as purely a genetic disease might be misguided

• Three major concerns about GLP-1 medications:

  • Downstream effects (vitamin absorption, gut health, muscle loss)
  • Loss of essential healthy habits
  • No clear exit strategy from the medication

  continue reading

253 episodes

Artwork
iconShare
 
Manage episode 465065632 series 3047232
Content provided by Matt and Chris Johnson and Chris Johnson. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Matt and Chris Johnson and Chris Johnson or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ppacc.player.fm/legal.

In this thought-provoking episode, Matt challenges the current narrative surrounding GLP-1 medications (like Ozempic and Wegovy) and obesity treatment.

He poses a crucial question: Are we focusing too much on survival instead of helping people truly thrive?

Key Points:

• The difference between surviving and thriving in healthcare

• Why treating obesity as purely a genetic disease might be misguided

• Three major concerns about GLP-1 medications:

  • Downstream effects (vitamin absorption, gut health, muscle loss)
  • Loss of essential healthy habits
  • No clear exit strategy from the medication

  continue reading

253 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Quick Reference Guide

Copyright 2025 | Privacy Policy | Terms of Service | | Copyright
Listen to this show while you explore
Play